It has been shown that TrkB positive cancer stem cells contribute to recurrence of TNBC in a mouse model [28] while p75 receptor expression is a characteristic of mitotically quiescent cancer stem cell population which enhances their chemoresistance [29]. The gene discussed is NTRK2; the disease is cancer.